Acute kidney injury (AKI) is prevalent in critically ill patients, especially in those needing extracorporeal membrane oxygenation (ECMO) due to cardiogenic shock or acute respiratory distress syndrome. The incidence of AKI in this patient population varies from 26% to 85%. This study explored the factors associated with AKI after the initiation of ECMO in the intensive care unit (ICU).
Methods
A retrospective cohort study was conducted, including patients aged 18 years and above undergoing veno-arterial or veno-venous ECMO between 1 January, 2020 and 1 May, 2023.
Results
A total of 267 patients undergoing ECMO were included in this study. The development of AKI was associated with the use of vasopressors, specifically norepinephrine (odds ratio [OR]: 3.7, 95% confidence interval [95% CI]: 1.65–8.14) and vasopressin (OR: 2.5, 95% CI: 1.49–4.30).The protective factors included heparin use (OR: 0.51, 95% CI: 0.26–0.97) and the absence of vasopressors (OR: 0.39, 95% CI: 0.17–0.77).
Conclusions
AKI poses a significant concern in critically ill patients undergoing ECMO. Multiple risk factors were identified, including vasopressor use and ECMOrelated complications. Identifying risks and protective factors is crucial for optimising ECMO management to reduce complications and mortality risk. Further studies are needed to understand the exact mechanisms of AKI during ECMO, which can inform the development of new targeted intervention checkpoints to improve outcomes in critically ill patients undergoing ECMO.
MouZHeJGuanT, et al.Acute kidney injury during extracorporeal membrane oxygenation: VA ECMO versus VV ECMO. J Intensive Care Med2022; 37(6): 743–752.
4.
VillaGKatzNRoncoC. Extracorporeal membrane oxygenation and the kidney. Cardiorenal Med2015; 6: 50–60.
5.
GuMMeiXLZhaoYN. A review on extracorporeal membrane oxygenation and kidney injury. J Biochem Mol Toxicol2021; 35: e22673.
6.
KilburnDJShekarKFraserJF. The complex relationship of extracorporeal membrane oxygenation and acute kidney injury: causation or association?BioMed Res Int2016; 2016: 1094296.
7.
HenryRACesarQRMichelPG, et al.Factors associated with the initiation of renal replacement therapy in patients on VV-ECMO: a case-control study. J Intensive Care Med2025; 40(6): 623–631.
8.
Robayo-AmorteguiHQuintero-AltareAFlorez-NavasC, et al.Fluid dynamics of life: exploring the physiology and importance of water in the critical illness. Front Med2024; 11: 1368502.
9.
MarikPELinde-ZwirbleWTBittnerEA, et al.Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med2017; 43(5): 625–632.
10.
Valenzuela-FacciniNPoveda-HenaoCFlórez-NavasC, et al.Outcomes of ECMO support with polypropylene membrane during pandemic times: a retrospective cohort study. BMC Pulm Med2024; 24(1): 37.
11.
ChenWPeiMChenC, et al.Independent risk factors of acute kidney injury among patients receiving extracorporeal membrane oxygenation. BMC Nephrol2023; 24(1): 81.
12.
HarrisPATaylorRThielkeR, et al.Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf2009; 42(2): 377–381.
13.
CombesAHajageDCapellierG, et al.Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med2018; 378(21): 1965–1975.
14.
BaranDAGrinesCLBaileyS, et al.SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of cardiology (ACC), the American heart association (AHA), the society of critical care medicine (SCCM), and the society of thoracic surgeons (STS) in April 2019. Cathet Cardiovasc Interv2019; 94(1): 29–37.
15.
ThieleHDe Waha-ThieleSFreundA, et al.State of the art: management of cardiogenic shock. EuroIntervention2021; 17: 1132–1151.
16.
CharlsonMEPompeiPAlesKL, et al.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis1987; 40(5): 373–383.
17.
KnausWADraperEAWagnerDP, et al.Apache II: a severity of disease classification system. Crit Care Med1985; 13(10): 818–829.
18.
VincentJLDe MendonçaACantraineF, et al.Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. working group on sepsis-related problems of the European Society of Intensive Care Medicine. Crit Care Med1998; 26(11): 1793–1800.
19.
SchmidtMBaileyMSheldrakeJ, et al.Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure: the Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med2014; 189(11): 1374–1382.
20.
SchmidtMBurrellARobertsL, et al.Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J2015; 36(33): 2246–2256.
21.
MohlerJGArmstrongBW. The oxygen deficit and debt for normal and non-athletic men. Respir Physiol1973; 17(2): 248–262.
22.
DunhamCMSiegelJHWeireterL, et al.Oxygen debt and metabolic acidemia as quantitative predictors of mortality and the severity of the ischemic insult in hemorrhagic shock. Crit Care Med1991; 19(2): 231–243.
23.
Perez-GarzonMPoveda-HenaoCBastidas-GoyesA, et al.Oxygen debt as predictor of mortality and multiple organ dysfunction syndrome in severe COVID-19 patients: a retrospective study. J Intensive Care Med2024; 39(4): 358–367.
24.
KhwajaA. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract2012; 120(4): c179–c184.
25.
Section 2: AKI definition. Kidney Int Suppl2011; 2(1):19–36.
26.
TsaiTYChienHTsaiFC, et al.Comparison of RIFLE, AKIN, and KDIGO classifications for assessing prognosis of patients on extracorporeal membrane oxygenation. J Formos Med Assoc2017; 116(11): 844–851.
27.
GaudrySHajageDMartin-LefevreL, et al.Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet2021; 397(10281): 1293–1300.
28.
The STARRT-AKI Investigators. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med2020; 383(5): 240–251.
29.
BarbarSDClere-JehlRBourredjemA, et al.Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med2018; 379(15): 1431–1442.
30.
GibneyNHosteEBurdmannEA, et al.Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol2008; 3(3): 876–880.
31.
LiuZLiuDWangZ, et al.Association between inflammatory biomarkers and acute respiratory distress syndrome or acute lung injury risk: a systematic review and meta-analysis. Wien Klin Wochenschr2022; 134(1–2): 24–38.
32.
MishraRCSodhiKPrakashKC, et al.ISCCM guidelines on acute kidney injury and renal replacement therapy. Indian J Crit Care Med2022; 26(S2): S13–S42.
33.
MouZGuanTChenL. Risk factors of acute kidney injury in ECMO patients: a systematic review and meta-analysis. J Intensive Care Med2022; 37(2): 267–277.
34.
JiangYJXiXMJiaHM, et al.Risk factors, clinical features and outcome of new-onset acute kidney injury among critically ill patients: a database analysis based on prospective cohort study. BMC Nephrol2021; 22(1): 289.
35.
MacLarenGBrodieDLorussoR, et al.Extracorporeal life support: the ELSO red book. 6th ed.Ann Arbor, MI: Extracorporeal Life Support Organization, 2017, pp. 345–350.
36.
Robayo-AmorteguiHForero-DelgadilloAPérez-GarzónM, et al.Severe gastrointestinal injury associated with SARS-CoV-2 infection: thrombosis or inflammation? a retrospective case series study. Medicine (Baltim)2022; 101(42): e31094.
37.
ConnorRJ. Sample size for testing differences in proportions for the paired-sample design. Biometrics1987; 43(1): 207–211.
ChenFTChenSWWuVCC, et al.Impact of massive blood transfusion during adult extracorporeal membrane oxygenation support on long-term outcomes: a nationwide cohort study in Taiwan. BMJ Open2020; 10(6): e035486.
40.
MeyerDEReynoldsJWHobbsR, et al.The incidence of transfusion-related acute lung injury at a large, urban tertiary medical center: a decade’s experience. Anesth Analg2018; 127(2): 444–449.
41.
WuMLuanYYLuJF, et al.Platelet count as a new biomarker for acute kidney injury induced by hemorrhagic shock. Platelets2020; 31(1): 94–102.
42.
ChaoCTTsaiHBChiangCK, et al.Thrombocytopenia on the first day of emergency department visit predicts higher risk of acute kidney injury among elderly patients. Scand J Trauma Resuscitation Emerg Med2017; 25(1): 11.
43.
KertaiMDZhouSKarhausenJA, et al.Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology2016; 124(2): 339–352.
44.
ZarychanskiRHoustonDS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematology Am Soc Hematol Educ Program2017; 2017(1): 660–666.
45.
MachMHasanWAndreasM, et al.Evaluating the association between contrast medium dosage and acute kidney injury in transcatheter aortic valve replacement using different predictive models. J Clin Med2020; 9(11): 3476.
46.
AnthonCTPèneFPernerA, et al.Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU). Intensive Care Med2023; 49(11): 1327–1338.
47.
NguyenTCCruzMACarcilloJA. Thrombocytopenia-associated multiple organ failure and acute kidney injury. Crit Care Clin2015; 31(4): 661–674.
48.
LuYZhangQJiangJ. Development and validation of a prediction model for in-hospital mortality of patients with severe thrombocytopenia. Sci Rep2022; 12(1): 6316.
49.
Garzón RuizJPGiraldo BejaranoEMercado DíazMA, et al.Anticoagulation in ECMO: target values to reduce hemorrhagic complications in adults. A retrospective cohort study. ASAIO J2025. Available from: https://doi.org/10.1097/MAT.0000000000002415
50.
SmilowitzNRHadeEMKornblithLZ, et al.Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial. Res Pract Thromb Haemost2023; 7(6): 102167.
51.
ZhouZPZhongLLiuY, et al.Impact of early heparin therapy on mortality in critically ill patients with sepsis-associated acute kidney injury: a retrospective study from the MIMIC-IV database. Front Pharmacol2023; 14: 1200667.
52.
NunezJIGoslingAFO’GaraB, et al.Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis. Intensive Care Med2022; 48(2): 213–224.
53.
PilarczykKHuengesKBewigB, et al.Acute kidney injury in patients with severe ARDS requiring extracorporeal membrane oxygenation: incidence, prognostic impact and risk factors. J Clin Med2022; 11(4): 1079.
54.
ChiuLCChuangLPLinSW, et al.Cumulative fluid balance during extracorporeal membrane oxygenation and mortality in patients with acute respiratory distress syndrome. Membranes2021; 11(8): 567.
55.
LeeJHWonJYKimJE, et al.Association between cumulative fluid balance and outcomes in acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation. J Chest Surg2021; 54(1): 36–44.
56.
KimHPaekJHSongJH, et al.Permissive fluid volume in adult patients undergoing extracorporeal membrane oxygenation treatment. Crit Care2018; 22(1): 270.
57.
HuRTLankadevaYRYanaseF, et al.Continuous bladder urinary oxygen tension as a new tool to monitor medullary oxygenation in the critically ill. Crit Care2022; 26(1): 389.
58.
KarkoutiKGrocottHPHallR, et al.Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study. Can J Anaesth2015; 62(4): 377–384.
59.
ChiuCFongNLazzareschiD, et al.Fluids, vasopressors, and acute kidney injury after major abdominal surgery between 2015 and 2019: a multicentre retrospective analysis. Br J Anaesth2022; 129(3): 317–326.
60.
HuettePMoussaMDBeylsC, et al.Association between acute kidney injury and norepinephrine use following cardiac surgery: a retrospective propensity score-weighted analysis. Ann Intensive Care2022; 12(1): 61.
61.
NaSJChungCRChoYH, et al.Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO. Rev Esp Cardiol2019; 72(1): 40–47.
62.
LankadevaYRCochraneADMarinoB, et al.Strategies that improve renal medullary oxygenation during experimental cardiopulmonary bypass may mitigate postoperative acute kidney injury. Kidney Int2019; 95(6): 1338–1346.
63.
GaoXNinanJBohmanJK, et al.Extracorporeal membrane oxygenation and acute kidney injury: a single-center retrospective cohort. Sci Rep2023; 13(1): 15112.
64.
MichelPGClaudiaPHAndreaRS, et al.Oxygen debt as a predictor of high-flow nasal cannula therapy failure in SARS-CoV-2 patients with acute respiratory failure: a retrospective cohort study. Heart Lung2024; 64: 176–181.
65.
AsadaTAokiYSugiyamaT, et al.Organ system network disruption in nonsurvivors of critically ill patients. Crit Care Med2016; 44(1): 83–90.
66.
ProwleJRKolicIPurdell-LewisJ, et al.Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol2014; 9(6): 1015–1023.
67.
MatsuuraRDoiKRabbH. Acute kidney injury and distant organ dysfunction–network system analysis. Kidney Int2023; 103(2): 1041–1055.
